What antibiotic regimen is appropriate for an adult with acute bacterial sinusitis who is allergic to cephalexin (first‑generation cephalosporin)?

Antibiotic Management for Acute Bacterial Sinusitis in a Patient Allergic to Cephalexin

For a patient with acute bacterial sinusitis and documented cephalexin allergy, use a cephalosporin with a dissimilar side chain (such as cefuroxime, cefpodoxime, or cefdinir) as first-line therapy, or reserve respiratory fluoroquinolones for severe/anaphylactic reactions. The 2023 Dutch antibiotic allergy guideline explicitly states that cephalosporins with dissimilar side chains can be used safely regardless of reaction severity or timing, while penicillins with dissimilar side chains are also appropriate alternatives. 1

Understanding Cephalexin Allergy and Cross-Reactivity

• Cephalexin (a first-generation cephalosporin) shares a similar side chain with certain penicillins (amoxicillin, ampicillin), but cross-reactivity with other cephalosporins having dissimilar side chains is negligible. The Dutch guideline recommends that patients with cephalexin allergy can receive cephalosporins with dissimilar side chains (strong recommendation, moderate-quality evidence). 1

• For non-severe, delayed-type cephalexin allergy, penicillins with dissimilar side chains can be used regardless of timing (strong recommendation). For reactions occurring >1 year ago, even penicillins with similar side chains may be considered (weak recommendation). 1

• For immediate-type (IgE-mediated) cephalexin allergy, cephalosporins with dissimilar side chains remain safe options, while carbapenems or fluoroquinolones provide additional alternatives if needed (weak recommendation). 1

First-Line Antibiotic Regimens

Preferred Option: Second- or Third-Generation Cephalosporins (Dissimilar Side Chains)

• Cefuroxime axetil, cefpodoxime proxetil, or cefdinir for 10 days are the recommended first-line agents for penicillin-allergic patients with acute bacterial sinusitis, providing excellent coverage against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. 2, 3

• Cefpodoxime 200 mg twice daily for 10 days offers superior activity against H. influenzae compared to second-generation agents and is explicitly recommended for non-anaphylactic penicillin allergy. 3

• Cefuroxime axetil 250–500 mg twice daily for 10 days provides enhanced activity against β-lactamase-producing organisms and is a validated alternative. 3, 4

• Cefdinir 300 mg twice daily for 10 days is another third-generation option with excellent pathogen coverage and high patient acceptance. 2, 3

• These cephalosporins are unlikely to cross-react with cephalexin because they possess different R1 side chains, making them safe even in patients with documented cephalexin allergy. 4

Alternative Option: Respiratory Fluoroquinolones (Reserve for Severe Allergy)

• Levofloxacin 500 mg once daily for 10–14 days or moxifloxacin 400 mg once daily for 10 days should be reserved for patients with severe (anaphylactic) cephalexin allergy or when cephalosporins are contraindicated, providing 90–92% predicted clinical efficacy against multidrug-resistant pathogens. 2, 3, 5

• Fluoroquinolones should not be used as routine first-line therapy in patients with non-severe cephalexin allergy, as this promotes antimicrobial resistance; reserve them for documented treatment failures or severe allergic reactions. 2

Antibiotics to Avoid

• Amoxicillin and amoxicillin-clavulanate should be avoided if the cephalexin allergy was severe or recent (<1 year for delayed-type reactions), because cephalexin shares a similar side chain with amoxicillin, increasing cross-reactivity risk. 1

• Azithromycin and other macrolides are explicitly contraindicated due to resistance rates exceeding 20–25% for S. pneumoniae and H. influenzae, making treatment failure highly likely. 2, 5

• Trimethoprim-sulfamethoxazole should not be used because resistance approaches 50% in S. pneumoniae and 27% in H. influenzae. 5

• First-generation cephalosporins (including cephalexin itself) are inappropriate for sinusitis because they provide inadequate coverage against H. influenzae, with approximately 50% of strains producing β-lactamase. 2

Diagnostic Criteria Before Initiating Antibiotics

• Antibiotics are indicated only when acute bacterial rhinosinusitis is confirmed by one of three patterns: (1) persistent symptoms ≥10 days with purulent nasal discharge plus obstruction or facial pain/pressure; (2) severe symptoms ≥3–4 consecutive days with fever ≥39°C, purulent discharge, and facial pain; or (3) "double sickening" (initial improvement followed by worsening within 10 days). 2

• Approximately 98–99.5% of acute rhinosinusitis cases are viral and resolve spontaneously within 7–10 days; antibiotics should not be prescribed for symptoms <10 days unless severe features are present. 2

Treatment Duration and Monitoring

• Standard treatment duration is 10 days for cephalosporins or 10–14 days for fluoroquinolones, or until the patient is symptom-free for 7 consecutive days (typically 10–14 days total). 2, 3, 5

• Reassess at 3–5 days: if no clinical improvement (persistent purulent drainage, unchanged facial pain, or worsening), switch to a respiratory fluoroquinolone or high-dose amoxicillin-clavulanate (if the allergy permits based on timing and severity). 2

• Reassess at 7 days: persistent or worsening symptoms warrant confirmation of diagnosis, exclusion of complications (orbital cellulitis, meningitis, intracranial abscess), and consideration of imaging or ENT referral. 2

Essential Adjunctive Therapies (Add to All Patients)

• Intranasal corticosteroids (mometasone, fluticasone, or budesonide) twice daily significantly reduce mucosal inflammation and accelerate symptom resolution; supported by strong evidence from multiple randomized controlled trials. 2, 3

• Saline nasal irrigation 2–3 times daily provides symptomatic relief and aids mucus clearance. 2, 3

• Analgesics (acetaminophen or ibuprofen) for pain and fever control. 2, 3

Referral to Otolaryngology

• Refer immediately if: (1) no improvement after 7 days of appropriate second-line antibiotic therapy; (2) worsening symptoms at any point; (3) suspected complications (severe headache, visual changes, periorbital swelling, altered mental status); or (4) recurrent sinusitis (≥3 episodes per year) requiring evaluation for underlying allergic rhinitis, immunodeficiency, or anatomic abnormalities. 2

Common Pitfalls to Avoid

• Do not assume all cephalosporin allergies preclude use of other cephalosporins; the Dutch guideline explicitly permits cephalosporins with dissimilar side chains even in patients with documented cephalexin allergy. 1

• Do not prescribe antibiotics for symptoms <10 days unless severe features (fever ≥39°C with purulent discharge for ≥3 consecutive days) are present. 2

• Ensure adequate treatment duration (minimum 10 days) to prevent relapse and resistance development. 2, 3

• Reserve fluoroquinolones for severe allergy or treatment failure to limit resistance; do not use as routine first-line therapy when cephalosporins with dissimilar side chains are safe and effective. 2, 3